Redmile Group

Venture Capital

Healthcare-focused hedge fund and crossover investor backing biotech, therapeutics, and life sciences companies from early stage to public markets.

Seed
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
Therapeutics
Headquarters
San Francisco, United States
Founded
2007
AUM
$1.4B
Total Investments
40
Last Investment
Feb 2025
Geographic Focus
United States

Investment Thesis

Healthcare-specialist crossover fund investing across the continuum from early venture to public biotech and life sciences companies.

Investment History

Sign up to view investment history

Create a free account to see deal history, investment amounts, and round details.

Create Free Account